Reminder of important clinical lesson
Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use
St Helens and Knowsley Hospitals NHS Trust, Medicine-Gastro, Whiston Hospital, Warrington Prescot, L35 5DR, UK
Correspondence to:
drmuthuram{at}yahoo.co.in
Objective: To report a case of hepatitis, rhabdomyolysis and multi-organ failure resulting from the use of statins.
Case summary: A 70 year old Caucasian woman was admitted with general malaise, myalgia and jaundice. She was being treated with a statin for aortic stenosis, the dose of which had been increased approximately 6 months earlier. Investigations showed evidence of hepatitis and rhabdomyolysis resulting in multi-organ failure, eventually leading to her death.
Discussion: Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treatment of hypercholesterolaemia. The use of high dose statin is becoming increasingly common with emerging evidence suggesting improved outcomes in various conditions. Statins have transformed the care of patients with vascular disease. Statins generally have an excellent safety profile and low risk of adverse reactions, but cases of rhabdomyolysis and hepatitis resulting from their use have been reported.
Conclusion: While there is good evidence suggesting improved outcomes with use of high dose statins, the potential drug interactions and adverse effects need close attention. All patients started on statin therapy should be counselled regarding the signs and symptoms of muscle injury, particularly those who are on drugs that may have an interaction. In this patient the Naranjo probability scale revealed a probable adverse reaction associated with atorvastatin therapy.
Register for free content
The full text of all Editor's Choice articles and summaries of every article are free without registration
The full text of Images in ... articles are free to registered users
Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource
Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog
